Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases Jun 17, 2019 | IVERIC bio Reports First Quarter 2019 Financial and Operating Results May 08, 2019 | IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019 May 01, 2019 | Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio Apr 16, 2019 | Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases Apr 11, 2019 | Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 | Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference Mar 06, 2019 | Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results Feb 26, 2019 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 | Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 | Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last »
IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases Jun 17, 2019 |
IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019 May 01, 2019 |
Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio Apr 16, 2019 |
Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases Apr 11, 2019 |
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 |
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 |
Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases Jun 17, 2019 | IVERIC bio Reports First Quarter 2019 Financial and Operating Results May 08, 2019 | IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019 May 01, 2019 | Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio Apr 16, 2019 | Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases Apr 11, 2019 | Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 | Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference Mar 06, 2019 | Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results Feb 26, 2019 | Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 | Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 | Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page next › Last page last »
IVERIC bio Enters into Strategic Manufacturing Relationship with Catalent’s Paragon Gene Therapy for Orphan Inherited Retinal Diseases Jun 17, 2019 |
IVERIC bio to Report First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019 May 01, 2019 |
Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio Apr 16, 2019 |
Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases Apr 11, 2019 |
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day Mar 14, 2019 |
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019 Feb 19, 2019 |
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference Jan 03, 2019 |
